Adam Kaplin

Insider Reports History

Location
New York, NY
Signature
/s/ Michelle Yanez, Attorney-in-Fact for Adam Kaplin
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Adam Kaplin:

Company Role Class Num Shares Value Price $ Report Date Ownership
MIRA PHARMACEUTICALS, INC. Pres. & Chief Scientific Off. Common Stock 200,000 $310,820 $1.55 02 Aug 2023 Direct
MyMD Pharmaceuticals, Inc. Chief Scientific Officer Employee Stock Option (Right to Buy) 150,000 07 Jun 2023 Direct

Insider Reports Filed by Adam Kaplin

Symbol Company Period Transactions Value $ Form Type Role Filing Time
MIRA MIRA PHARMACEUTICALS, INC. 02 Aug 2023 0 $0 3 Pres. & Chief Scientific Off. 02 Aug 2023, 17:55
TNFA MyMD Pharmaceuticals, Inc. 07 Jun 2023 1 $0 4 Chief Scientific Officer 09 Jun 2023, 18:00
TNFA MyMD Pharmaceuticals, Inc. 14 Oct 2021 1 $0 4 Chief Scientific Officer 15 Oct 2021, 17:23